The 12th Annual Biosimilars Asia is a conference that covers topics such as:
- The latest development in regulations and Government pricing plans in China, EU, US, Korea and India, how to access these markets and gain approvals
- In-depth content from leading biosimilars companies and case studies on market access and commercialization strategies
- Innovative and cost effective approaches in biosimilars production and development
- Insights on key success factors for entering the biosimilars investment space with different business models as well as developing win-win partnerships
- The latest market intelligence and analysis and identify new trends and opportunities in Biosimilars RD, contract manufacturing and commercialization in Asia
The 12th Annual Biosimilars Asia brings together senior-level decision makers involved in the biopharmaceutical industry from the US, Asia and Europe.
